Gradyent is an AI cloud platform based in Utrecht, The Netherlands, founded in 2019. It specializes in optimizing heating systems for district heating companies, effectively reducing CO2 emissions and improving energy efficiency. Utilizing Digital Twin technology, Gradyent creates a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows real-time optimization of heating systems, enabling users to simulate future scenarios and make informed decisions. As a result, clients experience significant savings, with an average reduction of 20% in heat loss, 10% in CO2 emissions, and 5-10% in fuel costs. Gradyent's platform also offers dynamic forecasting and the capability to monitor network status, making it accessible for clients to securely manage their networks from anywhere at any time.
Minze Health
Series A in 2024
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.
Chainels is a comprehensive tenant experience platform that focuses on enhancing the management of multi-tenant environments such as shopping centers, mixed-use developments, transport hubs, offices, and residential buildings. Based in Rotterdam, the company serves over 400 communities, encompassing around 50,000 companies and households across multiple countries. Chainels aims to digitalize operations and foster a sense of community by providing an intuitive app that facilitates communication, amenities management, data reporting, and marketing efforts. By streamlining property management processes through features like direct communication channels and an efficient ticketing system, Chainels empowers stakeholders to improve tenant engagement and retention. Their client base includes prominent organizations such as Multi Corporation, Amvest/Fuzer, and CBRE, highlighting their significant presence in the property management sector.
Minze Health
Seed Round in 2022
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, founded in 2019. It specializes in optimizing heating systems for district heating companies, effectively reducing CO2 emissions and improving energy efficiency. Utilizing Digital Twin technology, Gradyent creates a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows real-time optimization of heating systems, enabling users to simulate future scenarios and make informed decisions. As a result, clients experience significant savings, with an average reduction of 20% in heat loss, 10% in CO2 emissions, and 5-10% in fuel costs. Gradyent's platform also offers dynamic forecasting and the capability to monitor network status, making it accessible for clients to securely manage their networks from anywhere at any time.
Finquest
Seed Round in 2022
Finquest is a leading deal origination provider that specializes in delivering personalized connections for clients seeking mergers and acquisitions (M&A) and direct investment opportunities across Europe, North America, and the Asia-Pacific region. Utilizing a unique database and advanced machine learning techniques, Finquest offers targeted and curated introductions, facilitating a more efficient deal-making process while ensuring complete confidentiality. The company's platform focuses on the middle market, connecting institutional investors with potential investment opportunities and enabling corporate buyers to identify relevant acquirers. Headquartered in Singapore, Finquest operates offices in key financial centers including New York, Dallas, London, Paris, Frankfurt, Luxembourg, Bangalore, and Hong Kong, broadening market access for its clients.
Sensolus
Venture Round in 2020
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, offering comprehensive solutions for tracking and monitoring these items through advanced wireless technology. Founded in 2013 and based in Ghent, Belgium, the company combines expertise in low-power networks and wireless sensor design to deliver innovative tracking systems, including their personal product line, STICKNTRACK. Sensolus provides a cloud-based platform that enables users to access real-time information about their assets, making the management of valuable equipment in industries such as manufacturing, waste management, cargo transport, logistics, and automotive efficient and straightforward. Their offerings focus on affordable, easy-to-install, and maintenance-free tracking solutions, ensuring seamless asset management for users.
Gradyent
Seed Round in 2020
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, founded in 2019. It specializes in optimizing heating systems for district heating companies, effectively reducing CO2 emissions and improving energy efficiency. Utilizing Digital Twin technology, Gradyent creates a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows real-time optimization of heating systems, enabling users to simulate future scenarios and make informed decisions. As a result, clients experience significant savings, with an average reduction of 20% in heat loss, 10% in CO2 emissions, and 5-10% in fuel costs. Gradyent's platform also offers dynamic forecasting and the capability to monitor network status, making it accessible for clients to securely manage their networks from anywhere at any time.
iSTAR Medical
Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.
Arkite NV
Venture Round in 2019
Arkite NV is a Belgian company, founded in 2015 and based in Genk, that focuses on manufacturing automation products designed to enhance manufacturing operations. Its primary product, the Human Interface Mate (HIM), assists operators by providing immediate warnings when incorrect operations occur and guiding them towards standardized work processes. The company prides itself on a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to its technological offerings, Arkite NV provides professional services, including process innovation consultancy, integration services, and training to support the implementation of its products. The company also aids clients in conducting time studies for technology innovation and improving quality systems, ultimately aiming to reduce waste and streamline operations.
icometrix
Series A in 2019
icometrix is a technology company that specializes in the analysis of brain MRI images using artificial intelligence. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, icometrix has established itself as a leader in providing standardized measurements for patients with neurological disorders. The company’s flagship product, MSmetrix, is designed to detect brain lesions and assess various brain metrics, including lesion volume and atrophy, with regulatory approvals in the EU, Canada, Brazil, and Australia. Based in Leuven, with an office in Boston, icometrix employs over 25 professionals and is internationally active. The company also serves as an image analysis expert in clinical trials and research studies, where it processes large volumes of brain imaging data to derive insights into conditions such as traumatic brain injury, epilepsy, Alzheimer's disease, and stroke. icometrix is certified in quality management and information security, underscoring its commitment to maintaining high standards in medical devices and data handling.
Confo Therapeutics
Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes the inherently unstable functional conformations of GPCRs, providing a robust framework for drug discovery. This innovative approach reveals previously inaccessible structural features of these receptors, facilitating the discovery of novel agonists and enhancing therapeutic interventions. By concentrating on stabilizing GPCRs, Confo Therapeutics aims to significantly advance the development of new treatments in the medical field.
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.
Arkite NV
Venture Round in 2017
Arkite NV is a Belgian company, founded in 2015 and based in Genk, that focuses on manufacturing automation products designed to enhance manufacturing operations. Its primary product, the Human Interface Mate (HIM), assists operators by providing immediate warnings when incorrect operations occur and guiding them towards standardized work processes. The company prides itself on a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to its technological offerings, Arkite NV provides professional services, including process innovation consultancy, integration services, and training to support the implementation of its products. The company also aids clients in conducting time studies for technology innovation and improving quality systems, ultimately aiming to reduce waste and streamline operations.
Sensolus
Seed Round in 2017
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, offering comprehensive solutions for tracking and monitoring these items through advanced wireless technology. Founded in 2013 and based in Ghent, Belgium, the company combines expertise in low-power networks and wireless sensor design to deliver innovative tracking systems, including their personal product line, STICKNTRACK. Sensolus provides a cloud-based platform that enables users to access real-time information about their assets, making the management of valuable equipment in industries such as manufacturing, waste management, cargo transport, logistics, and automotive efficient and straightforward. Their offerings focus on affordable, easy-to-install, and maintenance-free tracking solutions, ensuring seamless asset management for users.
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.
Diagenode
Venture Round in 2016
Diagenode is an international life sciences company established in 2003 in Liège, Belgium, with a presence in Sparta, New Jersey, and a sales office in the United Kingdom. The company specializes in developing and commercializing advanced instruments and reagent systems for life science research and molecular diagnostics. Diagenode offers a technology platform that includes Bioruptor shearing and IP-Star automation instruments, along with reagent kits and quality antibodies. These products are designed to enhance workflows in epigenetics research, biological sample preparation, and diagnostic assays, serving a diverse clientele that includes prominent epigenetics researchers, academic institutions, genome centers, core laboratories, and pharmaceutical and biotechnology companies.
iSTAR Medical
Series B in 2016
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.
Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that specializes in the invention and development of small molecule drugs targeting G-Protein Coupled Receptors (GPCRs). Founded in 1994 and formerly known as Euroscreen, the company focuses on developing innovative therapies for women's health disorders, with its lead product, fezolinetant, currently in Phase II clinical development. In addition to fezolinetant, Ogeda is advancing other small molecules aimed at treating various endocrine, central nervous system, and inflammatory conditions. The company maintains facilities in Brussels and Paris, and operates as a subsidiary of Astellas Pharma Inc. Through its research, Ogeda seeks to provide effective treatment options for hormone-dependent pathologies and other related health issues.
Avantium is a Dutch technology company specializing in advanced high-throughput research and development for energy, chemicals, and pharmaceutical industries. Headquartered in Amsterdam with state-of-the-art laboratories, Avantium's proprietary technology accelerates product and process innovation while reducing costs. With over 70 global clients, including industry leaders, Avantium has proven its technology's validity and commercial viability. The company focuses on developing new biofuels, bio-based chemicals, and novel crystal forms of marketed drugs under patent. Its team comprises highly educated professionals in catalysis, crystallography, organic chemistry, engineering, statistics, cheminformatics, and software development, collaborating closely with partner R&D organizations to drive innovation.
iSTAR Medical
Series A in 2013
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.
Trod Medical
Series B in 2013
Trod Medical S.A. is a medical device manufacturer founded in 2006, with its headquarters located in Leuven, Belgium, and a presence in the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in the development of radiofrequency (RF) ablation devices. Trod Medical's flagship product, the EncageTM, is a percutaneous RF device designed to ablate soft tissues with exceptional precision, significantly reducing collateral damage compared to conventional treatments. This advancement is particularly relevant in the treatment of prostate cancer, a prevalent condition that affects around 240,000 new patients annually in the United States. The company aims to address the limitations of existing therapies, which often lead to serious side effects such as erectile dysfunction and urinary incontinence. Through its focus on focal ablation techniques, Trod Medical is committed to improving patient outcomes and enhancing surgical efficacy.
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.
Trinean
Venture Round in 2012
Trinean is a Belgium-based technology provider specializing in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers for biomolecule quantification. Their flagship products, the DropSense™16 and DropSense™96, analyze up to 16 and 96 samples respectively, utilizing microfluidic chips for standardized sample analysis through DropPlates™ and Slides. Trinean's platform is enhanced with a software toolbox designed to improve data interpretation and lab automation, catering to the needs of biologics researchers.
EpiGan
Venture Round in 2011
EpiGaN is a Leuven, Belgium-based company specializing in the development of Gallium Nitride (GaN) on silicon wafers. The company focuses on providing III-nitride epitaxial materials that are designed for various commercial applications. EpiGaN's GaN materials offer higher power efficiency, which helps to reduce power losses in a range of uses, including AC drives, uninterruptible power supplies (UPS), and hybrid and electric vehicles. Through its innovative technology, EpiGaN aims to enhance the performance and efficiency of electronic systems across multiple industries.
Ducatt
Venture Round in 2010
Ducatt NV is a clean-tech start-up located in Belgium that specializes in the manufacturing of solar glasses. The company's products are designed to enhance the efficiency of solar systems by utilizing ultra-clear patterned glasses available in various thicknesses. Ducatt aims to provide clients with an affordable solution to improve solar energy usage, contributing to the advancement of clean energy technologies.
Anteryon International
Venture Round in 2010
Anteryon International, established in 2006, specializes in designing, manufacturing, and distributing high-precision optical components. Its product portfolio includes a wide range of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, the company leverages its patented replication and opto-mechanical assembly technology, along with deep domain expertise, to deliver standard and customer-specific optical solutions. Headquartered in Eindhoven, the Netherlands, Anteryon International operates as a subsidiary of China Wafer Level CSP Co., Ltd.
Avantium
Venture Round in 2008
Avantium is a Dutch technology company specializing in advanced high-throughput research and development for energy, chemicals, and pharmaceutical industries. Headquartered in Amsterdam with state-of-the-art laboratories, Avantium's proprietary technology accelerates product and process innovation while reducing costs. With over 70 global clients, including industry leaders, Avantium has proven its technology's validity and commercial viability. The company focuses on developing new biofuels, bio-based chemicals, and novel crystal forms of marketed drugs under patent. Its team comprises highly educated professionals in catalysis, crystallography, organic chemistry, engineering, statistics, cheminformatics, and software development, collaborating closely with partner R&D organizations to drive innovation.
iNEWiT
Venture Round in 2008
iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. It specializes in identifying, designing, and creating applications and devices tailored for the mobile market. The company develops mobile video communication applications utilizing its patent-pending technology to transmit data, video, and sound across various wireless and wired platforms. iNEWiT also offers wireless communication technologies that encompass GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. Additionally, it provides plug-and-play products aimed at the business-to-consumer markets.
MAPPER Lithography
Series B in 2007
MAPPER Lithography B.V. is a company specializing in the development of maskless lithography infrastructure for the semiconductor industry. Established in 2000 and headquartered in Delft, the Netherlands, MAPPER Lithography focuses on producing advanced lithography machines that utilize multiple electron beam technology for semiconductor manufacturing. This innovative approach allows for the production of chips without the need for traditional masks, streamlining the manufacturing process. The company also operates a manufacturing facility in Moscow, Russian Federation, further supporting its operations in the semiconductor sector.
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.
TiGenix
Venture Round in 2003
TiGenix NV is a Belgium-based biomedical company specializing in innovative treatments for damaged and osteoarthritic joints. Founded as a spin-off from the Catholic University of Leuven and the University of Ghent, TiGenix leverages regenerative medicine to create durable therapies validated through controlled clinical studies. The company focuses on developing a portfolio of products aimed at addressing specific musculoskeletal issues, with a primary emphasis on cartilage damage, which significantly impairs patient mobility and function. TiGenix also explores the anti-inflammatory properties of stem cells to create novel therapies for serious medical conditions, particularly in areas where there is a high unmet medical need.